EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Interferon‐γ Mitigates Oxaliplatin‐Induced Neurotoxicity: Analogies With Connexin 43

Alessandra Toti iD, Valentina Ferrara iD, Elena Lucarini iD, Laura Micheli iD, Clara Ciampi iD, Francesco Margiotta iD, Daniel Venturi iD, Carmen Parisio iD, Elisabetta Gerace iD, Lorenzo Curti iD, Alessio Masi iD, Tommaso Mello iD und 3 weitere

CNS Neuroscience & Therapeutics · 2026-10 · 32 (10)

DOI: 10.1002/cns.71197 ↗

Kurz gefasst

Fachartikel in der Zeitschrift CNS Neuroscience & Therapeutics, online erschienen am 22.10.2026. Verfasst von Alessandra Toti und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neuroscience, Psychology, Drug Research and Child Health-NEUROFARBA-Pharmacology and Toxicology Section, University of Florence, Floren…. Hauptthemen laut MEDLINE: Oxaliplatin, Connexin 43, Interferon-gamma, Antineoplastic Agents. Die Arbeit nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Tuscany Region, National Recovery and Resilience Plan (NRRP), MNESYS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Chemotherapy‐induced neuropathy is a major side effect of platinum‐based drugs such as oxaliplatin. Given the context‐dependent pro‐inflammatory or neuroprotective actions of interferon‐γ (IFN‐γ), this study investigated its role in an in vitro model of oxaliplatin‐induced neurotoxicity (OIPN).

Methods

Rat organotypic spinal cord slices were exposed to oxaliplatin to model chemotherapy‐induced neurotoxicity responses in vitro. IFN‐γ cytotoxicity was assessed at 6 and 24 h. Neurotoxicity, inflammatory mediators, neurotrophic factors, and markers of glial and neuronal activation were analyzed by biochemical and immunohistochemical assays. Connexin 43 (Cx43) was assessed using Gap19 and Gap27 to probe hemichannel and gap‐junction contributions. Electrophysiological recordings characterized neuronal excitability.

Results

IFN‐γ (6.5–200 ng/mL) was non‐toxic and, at 65 ng/mL, significantly reduced oxaliplatin‐induced neurotoxicity, decreasing LDH release and suppressing pro‐inflammatory mediators (CCL2, SerpinA3N, CGRP, substance P, c‐Fos). IFN‐γ modulated its signaling by reducing IFNγR and increasing IRF1 expression. It prevented oxaliplatin‐induced overexpression of neurotrophic factors and reduced glial and neuronal hyperactivation markers, preserving neuronal integrity. IFN‐γ reduced Cx43 expression and hemichannel activity, and Gap19 reproduced selected protective effects. Electrophysiology showed attenuation of oxaliplatin‐induced neuronal hyperexcitability.

Conclusion

IFN‐γ attenuates oxaliplatin‐induced neurotoxic responses in an in vitro spinal cord model. The parallel reduction in Cx43 expression and hemichannel activity supports further investigation of Cx43 signaling as a candidate pharmacological target in OIPN.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OxaliplatinConnexin 43Interferon-gammaAntineoplastic AgentsOrganoplatinum CompoundsNeuroprotective AgentsAnimalsRatsSpinal CordNeuronsDose-Response Relationship, DrugRats, Sprague-Dawley

Stichwörter der Autor:innen

IFN‐γ dualismhemichannelsneuropathyneurotrophic factorspro‐inflammatory cytokinespinal cord

Substanzen

OxaliplatinConnexin 43Interferon-gammaAntineoplastic AgentsOrganoplatinum CompoundsNeuroprotective Agents

Autor:innen und Institutionen

  • Department of Neuroscience, Psychology, Drug Research and Child Health-NEUROFARBA-Pharmacology and Toxicology Section, University of Florence, Florence, Italy.
  • European Biomedical Research Institute of Salerno (EBRIS), Salerno, Italy.
  • Department of Health Science, University of Florence, Florence, Italy.
  • Clinical Gastroenterology Unit, Department of Biomedical Clinical and Experimental Sciences "Mario Serio", University of Florence, Florence, Italy.

ORCID-Profile: Alessandra Toti, Valentina Ferrara, Elena Lucarini, Laura Micheli, Clara Ciampi, Francesco Margiotta, Daniel Venturi, Carmen Parisio, Elisabetta Gerace, Lorenzo Curti, Alessio Masi, Tommaso Mello, Guido Mannaioni, Carla Ghelardini, Lorenzo Di Cesare Mannelli

Förderung

  • Tuscany Region
  • National Recovery and Resilience Plan (NRRP)
  • MNESYS
  • Italian Ministry of University and Research (MIUR)
  • Regione Toscana
  • Ministero dell'Istruzione e del Merito

Zitieren

APA

Toti, A., Ferrara, V., Lucarini, E., Micheli, L., Ciampi, C., Margiotta, F., Venturi, D., Parisio, C., Gerace, E., Curti, L., Masi, A., Mello, T., Mannaioni, G., Ghelardini, C., & Di Cesare Mannelli, L. (2026). Interferon‐γ Mitigates Oxaliplatin‐Induced Neurotoxicity: Analogies With Connexin 43. CNS Neuroscience & Therapeutics, 32(10). https://doi.org/10.1002/cns.71197

Vancouver

Toti A, Ferrara V, Lucarini E, Micheli L, Ciampi C, Margiotta F, et al. Interferon‐γ Mitigates Oxaliplatin‐Induced Neurotoxicity: Analogies With Connexin 43. CNS Neuroscience & Therapeutics. 2026;32(10). doi:10.1002/cns.71197

BibTeX
@article{Toti2026,
  author = {Toti, Alessandra and Ferrara, Valentina and Lucarini, Elena and Micheli, Laura and Ciampi, Clara and Margiotta, Francesco and Venturi, Daniel and Parisio, Carmen and Gerace, Elisabetta and Curti, Lorenzo and Masi, Alessio and Mello, Tommaso and Mannaioni, Guido and Ghelardini, Carla and Di Cesare Mannelli, Lorenzo},
  title = {Interferon‐γ Mitigates Oxaliplatin‐Induced Neurotoxicity: Analogies With Connexin 43},
  journal = {CNS Neuroscience & Therapeutics},
  year = {2026},
  volume = {32},
  number = {10},
  doi = {10.1002/cns.71197}
}
Kostenlos starten →